Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Travere Therapeutics Inc.

    NASDAQ: TVTX · Real-Time Price · USD
    21.13
    0.04 (0.19%)
    At close: May 15, 2025, 3:59 PM

    Travere Therapeutics Revenue

    Travere Therapeutics reported an annual revenue of $233.18M, reflecting a 60.55% growth. For the quarter ending March 31, 2025, Travere Therapeutics generated $81.73M in revenue.
    Revenue (ttm)
    $233.18M
    Revenue Growth
    60.55%
    Price / Sales Ratio
    5.89
    Revenue / Employee
    $605.65K
    Employees
    385
    Market Cap
    1.88B

    Revenue Chart

    Revenue History

    Fiscal Year End Revenue % Change
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist